Richard J. Rodgers

Insider Reports History

Location
Waltham, MA
Signature
/s/ Mark J. Casey, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Richard J. Rodgers:

Company Role Class Num Shares Value Price $ Report Date Ownership
ARDELYX, INC. Director Common Stock 413,543 $1,497,025 $3.62 18 Jun 2025 Direct
Opus Genetics, Inc. Director Common Stock 318,655 $283,602 $0.8900 30 Apr 2025 Direct
NOVAVAX INC Director Common Stock 28,490 $247,008 $8.67 29 Oct 2025 Direct
NOVAVAX INC Director Stock Option (Right to Buy) 28,326 $181,852 $6.42 20 Jun 2025 Direct
NOVAVAX INC Director Restricted Stock Units 0 $30,400 $8.00 29 Oct 2025 Direct
ARDELYX, INC. Director Stock Option (Right to Buy) 54,059 $0 $2.32 18 Jun 2025 Direct
Opus Genetics, Inc. Director Stock Option (Right to Buy) 79,592 30 Apr 2025 Direct
Sagimet Biosciences Inc. Director Stock Option (Right to Buy) 23,839 18 Jul 2023 Direct

Insider Reports Filed by Richard J. Rodgers

Symbol Company Period Transactions Value $ Form Type Role Filing Time
NVAX NOVAVAX INC 29 Oct 2025 2 $0 4 Director 30 Oct 2025, 16:30
NVAX NOVAVAX INC 20 Jun 2025 2 +$181,853 4 Director 24 Jun 2025, 18:40
ARDX ARDELYX, INC. 18 Jun 2025 3 $0 4 Director 23 Jun 2025, 20:42
NVAX NOVAVAX INC 12 Jun 2025 2 $0 4 Director 13 Jun 2025, 21:40
IRD Opus Genetics, Inc. 30 Apr 2025 2 $0 4 Director 02 May 2025, 17:09
ARDX ARDELYX, INC. 16 Jan 2025 2 +$55,000 4 Director 17 Jan 2025, 16:44
NVAX NOVAVAX INC 29 Oct 2024 2 $0 4 Director 02 Jan 2025, 16:52
ARDX ARDELYX, INC. 14 Jun 2024 2 $0 4 Director 17 Jun 2024, 18:54
NVAX NOVAVAX INC 12 Jun 2024 4 +$247,892 4 Director 14 Jun 2024, 16:05
IRD Ocuphire Pharma, Inc. 11 Jun 2024 2 $0 4 Director 13 Jun 2024, 17:31
IRD Ocuphire Pharma, Inc. 01 Jan 2024 1 $0 4 Director 03 Jan 2024, 18:03
IRD Ocuphire Pharma, Inc. 01 Nov 2023 1 $0 4 Director 13 Nov 2023, 17:42
NVAX NOVAVAX INC 29 Oct 2023 2 $0 4 Director 31 Oct 2023, 16:43
SGMT Sagimet Biosciences Inc. 18 Jul 2023 6 $0 4 Director 20 Jul 2023, 16:18
SGMT Sagimet Biosciences Inc. 13 Jul 2023 0 $0 3 Director 13 Jul 2023, 21:07
ARDX ARDELYX, INC. 15 Jun 2023 2 $0 4 Director 16 Jun 2023, 18:30
NVAX NOVAVAX INC 12 Jun 2023 2 $0 4 Director 13 Jun 2023, 16:48
IRD Ocuphire Pharma, Inc. 19 Apr 2023 1 $0 4 Interim CEO and President, Director 21 Apr 2023, 20:20
IRD Ocuphire Pharma, Inc. 11 Jan 2023 1 $0 4 Director 12 Jan 2023, 16:34
NVAX NOVAVAX INC 29 Oct 2022 2 $0 4 Director 01 Nov 2022, 17:10
NVAX NOVAVAX INC 29 Oct 2022 0 $0 3 Director 01 Nov 2022, 17:07
IRD Ocuphire Pharma, Inc. 03 Oct 2022 2 +$0.3148 4 Director 04 Oct 2022, 09:00
IRD Ocuphire Pharma, Inc. 01 Jul 2022 2 $0 4 Director 06 Jul 2022, 17:58
ARDX ARDELYX, INC. 15 Jun 2022 2 $0 4 Director 17 Jun 2022, 16:22
IRD Ocuphire Pharma, Inc. 13 Jun 2022 1 $0 4 Director 15 Jun 2022, 16:01
IRD Ocuphire Pharma, Inc. 01 Apr 2022 1 $0 4 Director 05 Apr 2022, 09:12
IRD Ocuphire Pharma, Inc. 03 Jan 2022 1 $0 4 Director 05 Jan 2022, 15:01
IRD Ocuphire Pharma, Inc. 01 Oct 2021 1 $0 4 Director 04 Oct 2021, 16:01
IRD Ocuphire Pharma, Inc. 01 Jul 2021 1 $0 4 Director 02 Jul 2021, 16:01
ARDX ARDELYX, INC. 16 Jun 2021 2 $0 4 Director 21 Jun 2021, 16:10
IRD Ocuphire Pharma, Inc. 07 Jun 2021 1 $0 4 Director 09 Jun 2021, 18:14